NCT06661655View on ClinicalTrials.gov

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

September 1, 2026

Conditions
Metabolic Syndrome XFatty LiverMASH - Metabolic Dysfunction-Associated SteatohepatitisMASLDNASH (Non-Alcoholic Steatohepatitis)Steatosis, LiverNAFLD
Interventions
DEVICE

Liver ultrasound

Hepatoscope is a point of care ultraportable ultrasound device that is capable of conventional grayscale ultrasound imaging, of 2D transient elastography (imaging + liver stiffness measurement), and of quantitative ultrasound properties measurement (ultrasound attenuation, backscattering coefficient, sound speed) related to liver steatosis.

Trial Locations (3)

49933

RECRUITING

University Hospital Angers, Angers

75013

NOT_YET_RECRUITING

Pitie Salpetriere University Hospital, Paris

92110

RECRUITING

Beaujon University Hospital, Clichy

Sponsors

Lead Sponsor

E-Scopics
All Listed Sponsors
lead

E-Scopics

INDUSTRY

NCT06661655 - Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients | Biotech Hunter | Biotech Hunter